<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">32747604</PMID>
      <DateCompleted>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>02</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2021</Year>
        <Month>04</Month>
        <Day>02</Day>
      </DateRevised>
      <Article PubModel="Electronic-Print">
        <Journal>
          <ISSN IssnType="Electronic">1098-5522</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>88</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2020</Year>
              <Month>Sep</Month>
              <Day>18</Day>
            </PubDate>
          </JournalIssue>
          <Title>Infection and immunity</Title>
          <ISOAbbreviation>Infect Immun</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Genome-Wide Assessment of Streptococcus agalactiae Genes Required for Survival in Human Whole Blood and Plasma.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">e00357-20</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.1128/IAI.00357-20</ELocationID>
        <Abstract>
          <AbstractText><i>Streptococcus agalactiae</i> (group B streptococcus, or GBS) is a common cause of bacteremia and sepsis in newborns, pregnant women, and immunocompromised patients. The molecular mechanisms used by GBS to survive and proliferate in blood are not well understood. Here, using a highly virulent GBS strain and transposon-directed insertion site sequencing (TraDIS), we performed genome-wide screens to discover novel GBS genes required for bacterial survival in human whole blood and plasma. The screen identified 85 and 41 genes that are required for GBS growth in whole blood and plasma, respectively. A common set of 29 genes was required in both whole blood and plasma. Targeted gene deletion confirmed that (i) genes encoding methionine transporter (<i>metP</i>) and manganese transporter (<i>mtsA</i>) are crucial for GBS survival in whole blood and plasma, (ii) gene W903_1820, encoding a small multidrug export family protein, contributes significantly to GBS survival in whole blood, (iii) the shikimate pathway gene <i>aroA</i> is essential for GBS growth in whole blood and plasma, and (iv) deletion of <i>srr1</i>, encoding a fibrinogen-binding adhesin, increases GBS survival in whole blood. Our findings provide new insight into the GBS-host interactions in human blood.</AbstractText>
          <CopyrightInformation>Copyright © 2020 American Society for Microbiology.</CopyrightInformation>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Zhu</LastName>
            <ForeName>Luchang</ForeName>
            <Initials>L</Initials>
            <Identifier Source="ORCID">0000-0002-4064-5781</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA lzhu2@houstonmethodist.org.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Yerramilli</LastName>
            <ForeName>Prasanti</ForeName>
            <Initials>P</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Pruitt</LastName>
            <ForeName>Layne</ForeName>
            <Initials>L</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Ojeda Saavedra</LastName>
            <ForeName>Matthew</ForeName>
            <Initials>M</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Cantu</LastName>
            <ForeName>Concepcion C</ForeName>
            <Initials>CC</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Olsen</LastName>
            <ForeName>Randall J</ForeName>
            <Initials>RJ</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Beres</LastName>
            <ForeName>Stephen B</ForeName>
            <Initials>SB</Initials>
            <Identifier Source="ORCID">0000-0003-3041-0185</Identifier>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Waller</LastName>
            <ForeName>Andrew S</ForeName>
            <Initials>AS</Initials>
            <AffiliationInfo>
              <Affiliation>Animal Health Trust, Newmarket, Suffolk, United Kingdom.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Musser</LastName>
            <ForeName>James M</ForeName>
            <Initials>JM</Initials>
            <AffiliationInfo>
              <Affiliation>Center for Molecular and Translational Human Infectious Diseases Research, Houston Methodist Research Institute, and Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, Texas, USA.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, New York, USA.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <GrantList CompleteYN="Y">
          <Grant>
            <GrantID>R21 AI139369</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
          <Grant>
            <GrantID>R21 AI146771</GrantID>
            <Acronym>AI</Acronym>
            <Agency>NIAID NIH HHS</Agency>
            <Country>United States</Country>
          </Grant>
        </GrantList>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
          <PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2020</Year>
          <Month>09</Month>
          <Day>18</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Infect Immun</MedlineTA>
        <NlmUniqueID>0246127</NlmUniqueID>
        <ISSNLinking>0019-9567</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D001426">Bacterial Proteins</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D016470" MajorTopicYN="N">Bacteremia</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D001426" MajorTopicYN="N">Bacterial Proteins</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D005798" MajorTopicYN="Y">Genes, Bacterial</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D056084" MajorTopicYN="N">Genetic Fitness</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016680" MajorTopicYN="N">Genome, Bacterial</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D050296" MajorTopicYN="N">Microbial Viability</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D016254" MajorTopicYN="N">Mutagenesis, Insertional</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013290" MajorTopicYN="N">Streptococcal Infections</DescriptorName>
          <QualifierName UI="Q000382" MajorTopicYN="Y">microbiology</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D013292" MajorTopicYN="N">Streptococcus agalactiae</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>
          <QualifierName UI="Q000254" MajorTopicYN="N">growth &amp; development</QualifierName>
          <QualifierName UI="Q000472" MajorTopicYN="N">pathogenicity</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D014774" MajorTopicYN="N">Virulence</DescriptorName>
          <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="Y">Streptococcus agalactiae
</Keyword>
        <Keyword MajorTopicYN="Y">TraDIS</Keyword>
        <Keyword MajorTopicYN="Y">bloodstream infections</Keyword>
        <Keyword MajorTopicYN="Y">group B streptococcus</Keyword>
      </KeywordList>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2020</Year>
          <Month>6</Month>
          <Day>16</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2020</Year>
          <Month>7</Month>
          <Day>26</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2021</Year>
          <Month>4</Month>
          <Day>7</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2020</Year>
          <Month>8</Month>
          <Day>5</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">32747604</ArticleId>
        <ArticleId IdType="pmc">PMC7504961</ArticleId>
        <ArticleId IdType="doi">10.1128/IAI.00357-20</ArticleId>
        <ArticleId IdType="pii">IAI.00357-20</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Schuchat A.
1998. 
Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin Microbiol Rev
11:497–513. doi:10.1128/CMR.11.3.497.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.11.3.497</ArticleId>
            <ArticleId IdType="pmc">PMC88893</ArticleId>
            <ArticleId IdType="pubmed">9665980</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weston EJ, Pondo T, Lewis MM, Martell-Cleary P, Morin C, Jewell B, Daily P, Apostol M, Petit S, Farley M, Lynfield R, Reingold A, Hansen NI, Stoll BJ, Shane AL, Zell E, Schrag SJ. 
2011. 
The burden of invasive early-onset neonatal sepsis in the United States, 2005-2008. Pediatr Infect Dis J
30:937–941. doi:10.1097/INF.0b013e318223bad2.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/INF.0b013e318223bad2</ArticleId>
            <ArticleId IdType="pmc">PMC3193564</ArticleId>
            <ArticleId IdType="pubmed">21654548</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stoll BJ, Hansen NI, Sanchez PJ, Faix RG, Poindexter BB, Van Meurs KP, Bizzarro MJ, Goldberg RN, Frantz ID III, Hale EC, Shankaran S, Kennedy K, Carlo WA, Watterberg KL, Bell EF, Walsh MC, Schibler K, Laptook AR, Shane AL, Schrag SJ, Das A, Higgins RD, Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. 2011. 
Early onset neonatal sepsis: the burden of group B Streptococcal and E. coli disease continues. Pediatrics
127:817–826. doi:10.1542/peds.2010-2217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1542/peds.2010-2217</ArticleId>
            <ArticleId IdType="pmc">PMC3081183</ArticleId>
            <ArticleId IdType="pubmed">21518717</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seale AC, Bianchi-Jassir F, Russell NJ, Kohli-Lynch M, Tann CJ, Hall J, Madrid L, Blencowe H, Cousens S, Baker CJ, Bartlett L, Cutland C, Gravett MG, Heath PT, Ip M, Le Doare K, Madhi SA, Rubens CE, Saha SK, Schrag SJ, Sobanjo-Ter Meulen A, Vekemans J, Lawn JE. 
2017. 
Estimates of the burden of group B streptococcal disease worldwide for pregnant women, stillbirths, and children. Clin Infect Dis
65:S200–S219. doi:10.1093/cid/cix664.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/cid/cix664</ArticleId>
            <ArticleId IdType="pmc">PMC5849940</ArticleId>
            <ArticleId IdType="pubmed">29117332</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Johri AK, Paoletti LC, Glaser P, Dua M, Sharma PK, Grandi G, Rappuoli R. 
2006. 
Group B Streptococcus: global incidence and vaccine development. Nat Rev Microbiol
4:932–942. doi:10.1038/nrmicro1552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrmicro1552</ArticleId>
            <ArticleId IdType="pmc">PMC2742968</ArticleId>
            <ArticleId IdType="pubmed">17088932</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, Lynfield R, Vagnone PS, Burzlaff K, Spina NL, Dufort EM, Schaffner W, Thomas AR, Farley MM, Jain JH, Pondo T, McGee L, Beall BW, Schrag SJ. 
2019. 
Epidemiology of invasive early-onset and late-onset group B streptococcal disease in the United States, 2006 to 2015. JAMA Pediatr
173:224–233. doi:10.1001/jamapediatrics.2018.4826.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamapediatrics.2018.4826</ArticleId>
            <ArticleId IdType="pmc">PMC6439883</ArticleId>
            <ArticleId IdType="pubmed">30640366</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Centers for Disease Control and Prevention. 2009. 
Trends in perinatal group B streptococcal disease–United States, 2000-2006. MMWR Morb Mortal Wkly Rep
58:109–112.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19214159</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, Craig AS, Schaffner W, Zansky SM, Gershman K, Stefonek KR, Albanese BA, Zell ER, Schuchat A, Schrag SJ, Active Bacterial Core Surveillance/Emerging Infections Program Network. 2008. 
Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA
299:2056–2065. doi:10.1001/jama.299.17.2056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jama.299.17.2056</ArticleId>
            <ArticleId IdType="pubmed">18460666</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kalin A, Acosta C, Kurinczuk JJ, Brocklehurst P, Knight M. 
2015. 
Severe sepsis in women with group B Streptococcus in pregnancy: an exploratory UK national case-control study. BMJ Open
5:e007976. doi:10.1136/bmjopen-2015-007976.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmjopen-2015-007976</ArticleId>
            <ArticleId IdType="pmc">PMC4606445</ArticleId>
            <ArticleId IdType="pubmed">26450426</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cape A, Tuomala RE, Taylor C, Puopolo KM. 
2013. 
Peripartum bacteremia in the era of group B streptococcus prophylaxis. Obstet Gynecol
121:812–818. doi:10.1097/AOG.0b013e3182888032.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1097/AOG.0b013e3182888032</ArticleId>
            <ArticleId IdType="pubmed">23635682</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zaleznik DF, Rench MA, Hillier S, Krohn MA, Platt R, Lee ML, Flores AE, Ferrieri P, Baker CJ. 
2000. 
Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. Clin Infect Dis
30:276–281. doi:10.1086/313665.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/313665</ArticleId>
            <ArticleId IdType="pubmed">10671328</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kankuri E, Kurki T, Carlson P, Hiilesmaa V. 
2003. 
Incidence, treatment and outcome of peripartum sepsis. Acta Obstet Gynecol Scand
82:730–735. doi:10.1034/j.1600-0412.2003.00265.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1034/j.1600-0412.2003.00265.x</ArticleId>
            <ArticleId IdType="pubmed">12848644</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Krohn MA, Hillier SL, Baker CJ. 
1999. 
Maternal peripartum complications associated with vaginal group B streptococci colonization. J Infect Dis
179:1410–1415. doi:10.1086/314756.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/314756</ArticleId>
            <ArticleId IdType="pubmed">10228062</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Anderson BL, Simhan HN, Simons KM, Wiesenfeld HC. 
2007. 
Untreated asymptomatic group B streptococcal bacteriuria early in pregnancy and chorioamnionitis at delivery. Am J Obstet Gynecol
196:524. doi:10.1016/j.ajog.2007.01.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ajog.2007.01.006</ArticleId>
            <ArticleId IdType="pubmed">17547879</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weisman LE, Stoll BJ, Cruess DF, Hall RT, Merenstein GB, Hemming VG, Fischer GW. 
1992. 
Early-onset group B streptococcal sepsis: a current assessment. J Pediatr
121:428–433. doi:10.1016/S0022-3476(05)81801-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0022-3476(05)81801-3</ArticleId>
            <ArticleId IdType="pubmed">1517922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Francois Watkins LK, McGee L, Schrag SJ, Beall B, Jain JH, Pondo T, Farley MM, Harrison LH, Zansky SM, Baumbach J, Lynfield R, Snippes Vagnone P, Miller LA, Schaffner W, Thomas AR, Watt JP, Petit S, Langley GE. 
2019. 
Epidemiology of invasive group B streptococcal infections among nonpregnant adults in the United States, 2008–2016. JAMA Intern Med
179:479–488. doi:10.1001/jamainternmed.2018.7269.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamainternmed.2018.7269</ArticleId>
            <ArticleId IdType="pmc">PMC6450309</ArticleId>
            <ArticleId IdType="pubmed">30776079</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jump RLP, Wilson BM, Baechle D, Briggs JM, Banks RE, Song S, Zappernick T, Perez F. 
2019. 
Risk factors and mortality rates associated with invasive group B Streptococcus infections among patients in the US Veterans Health Administration. JAMA Netw Open
2:e1918324. doi:10.1001/jamanetworkopen.2019.18324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1001/jamanetworkopen.2019.18324</ArticleId>
            <ArticleId IdType="pmc">PMC6991221</ArticleId>
            <ArticleId IdType="pubmed">31880800</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shelburne SA III, Tarrand J, Rolston KV. 
2013. 
Review of streptococcal bloodstream infections at a comprehensive cancer care center, 2000–2011. J Infect
66:136–146. doi:10.1016/j.jinf.2012.11.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jinf.2012.11.007</ArticleId>
            <ArticleId IdType="pubmed">23182968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jackson LA, Hilsdon R, Farley MM, Harrison LH, Reingold AL, Plikaytis BD, Wenger JD, Schuchat A. 
1995. 
Risk factors for group B streptococcal disease in adults. Ann Intern Med
123:415–420. doi:10.7326/0003-4819-123-6-199509150-00003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.7326/0003-4819-123-6-199509150-00003</ArticleId>
            <ArticleId IdType="pubmed">7639440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shea JE, Santangelo JD, Feldman RG. 
2000. 
Signature-tagged mutagenesis in the identification of virulence genes in pathogens. Curr Opin Microbiol
3:451–458. doi:10.1016/s1369-5274(00)00120-x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/s1369-5274(00)00120-x</ArticleId>
            <ArticleId IdType="pubmed">11050441</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Veeranagouda Y, Didier M. 
2017. 
Transposon insertion site sequencing (TIS-Seq): an efficient and high-throughput method for determining transposon insertion site(s) and their relative abundances in a PiggyBac transposon mutant pool by next-generation sequencing. Curr Protoc Mol Biol
120:21.35.1–21.35.11. doi:10.1002/cpmb.47.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/cpmb.47</ArticleId>
            <ArticleId IdType="pubmed">28967994</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Opijnen T, Bodi KL, Camilli A. 
2009. 
Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat Methods
6:767–772. doi:10.1038/nmeth.1377.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nmeth.1377</ArticleId>
            <ArticleId IdType="pmc">PMC2957483</ArticleId>
            <ArticleId IdType="pubmed">19767758</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Langridge GC, Phan MD, Turner DJ, Perkins TT, Parts L, Haase J, Charles I, Maskell DJ, Peters SE, Dougan G, Wain J, Parkhill J, Turner AK. 
2009. 
Simultaneous assay of every Salmonella Typhi gene using one million transposon mutants. Genome Res
19:2308–2316. doi:10.1101/gr.097097.109.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1101/gr.097097.109</ArticleId>
            <ArticleId IdType="pmc">PMC2792183</ArticleId>
            <ArticleId IdType="pubmed">19826075</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Barquist L, Mayho M, Cummins C, Cain AK, Boinett CJ, Page AJ, Langridge GC, Quail MA, Keane JA, Parkhill J. 
2016. 
The TraDIS toolkit: sequencing and analysis for dense transposon mutant libraries. Bioinformatics
32:1109–1111. doi:10.1093/bioinformatics/btw022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/bioinformatics/btw022</ArticleId>
            <ArticleId IdType="pmc">PMC4896371</ArticleId>
            <ArticleId IdType="pubmed">26794317</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Weiser JN, Rubens CE. 
1987. 
Transposon mutagenesis of group B streptococcus beta-hemolysin biosynthesis. Infect Immun
55:2314–2316. doi:10.1128/IAI.55.9.2314-2316.1987.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.55.9.2314-2316.1987</ArticleId>
            <ArticleId IdType="pmc">PMC260700</ArticleId>
            <ArticleId IdType="pubmed">3040595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooven TA, Catomeris AJ, Akabas LH, Randis TM, Maskell DJ, Peters SE, Ott S, Santana-Cruz I, Tallon LJ, Tettelin H, Ratner AJ. 
2016. 
The essential genome of Streptococcus agalactiae. BMC Genomics
17:406. doi:10.1186/s12864-016-2741-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-016-2741-z</ArticleId>
            <ArticleId IdType="pmc">PMC4881062</ArticleId>
            <ArticleId IdType="pubmed">27229469</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Clancy A, Lee MH, Jones AL, Rubens CE. 
2004. 
Construction and characterization of transposon TnphoZ for the identification of genes encoding exported proteins in Streptococcus agalactiae. FEMS Microbiol Lett
241:257–264. doi:10.1016/j.femsle.2004.10.029.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.femsle.2004.10.029</ArticleId>
            <ArticleId IdType="pubmed">15598541</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rubens CE, Wessels MR, Heggen LM, Kasper DL. 
1987. 
Transposon mutagenesis of type III group B Streptococcus: correlation of capsule expression with virulence. Proc Natl Acad Sci U S A
84:7208–7212. doi:10.1073/pnas.84.20.7208.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.84.20.7208</ArticleId>
            <ArticleId IdType="pmc">PMC299259</ArticleId>
            <ArticleId IdType="pubmed">2823254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doran KS, Engelson EJ, Khosravi A, Maisey HC, Fedtke I, Equils O, Michelsen KS, Arditi M, Peschel A, Nizet V. 
2005. 
Blood-brain barrier invasion by group B Streptococcus depends upon proper cell-surface anchoring of lipoteichoic acid. J Clin Investig
115:2499–2507. doi:10.1172/JCI23829.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI23829</ArticleId>
            <ArticleId IdType="pmc">PMC1193870</ArticleId>
            <ArticleId IdType="pubmed">16138192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Nizet V, Gibson RL, Chi EY, Framson PE, Hulse M, Rubens CE. 
1996. 
Group B streptococcal beta-hemolysin expression is associated with injury of lung epithelial cells. Infect Immun
64:3818–3826. doi:10.1128/IAI.64.9.3818-3826.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.64.9.3818-3826.1996</ArticleId>
            <ArticleId IdType="pmc">PMC174298</ArticleId>
            <ArticleId IdType="pubmed">8751934</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooven TA, Catomeris AJ, Bonakdar M, Tallon LJ, Santana-Cruz I, Ott S, Daugherty SC, Tettelin H, Ratner AJ. 
2017. 
The Streptococcus agalactiae stringent response enhances virulence and persistence in human blood. Infect Immun
86:e00612-17. doi:10.1128/IAI.00612-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00612-17</ArticleId>
            <ArticleId IdType="pmc">PMC5736797</ArticleId>
            <ArticleId IdType="pubmed">29109175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones AL, Knoll KM, Rubens CE. 
2000. 
Identification of Streptococcus agalactiae virulence genes in the neonatal rat sepsis model using signature-tagged mutagenesis. Mol Microbiol
37:1444–1455. doi:10.1046/j.1365-2958.2000.02099.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2958.2000.02099.x</ArticleId>
            <ArticleId IdType="pubmed">10998175</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kuypers JM, Heggen LM, Rubens CE. 
1989. 
Molecular analysis of a region of the group B streptococcus chromosome involved in type III capsule expression. Infect Immun
57:3058–3065. doi:10.1128/IAI.57.10.3058-3065.1989.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.57.10.3058-3065.1989</ArticleId>
            <ArticleId IdType="pmc">PMC260770</ArticleId>
            <ArticleId IdType="pubmed">2550369</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wessels MR, Haft RF, Heggen LM, Rubens CE. 
1992. 
Identification of a genetic locus essential for capsule sialylation in type III group B streptococci. Infect Immun
60:392–400. doi:10.1128/IAI.60.2.392-400.1992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.60.2.392-400.1992</ArticleId>
            <ArticleId IdType="pmc">PMC257641</ArticleId>
            <ArticleId IdType="pubmed">1309720</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Spellerberg B, Pohl B, Haase G, Martin S, Weber-Heynemann J, Lütticken R. 
1999. 
Identification of genetic determinants for the hemolytic activity of Streptococcus agalactiae by ISS1 transposition. J Bacteriol
181:3212–3219. doi:10.1128/JB.181.10.3212-3219.1999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.181.10.3212-3219.1999</ArticleId>
            <ArticleId IdType="pmc">PMC93778</ArticleId>
            <ArticleId IdType="pubmed">10322024</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Quach D, van Sorge NM, Kristian SA, Bryan JD, Shelver DW, Doran KS. 
2009. 
The CiaR response regulator in group B Streptococcus promotes intracellular survival and resistance to innate immune defenses. J Bacteriol
191:2023–2032. doi:10.1128/JB.01216-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01216-08</ArticleId>
            <ArticleId IdType="pmc">PMC2655536</ArticleId>
            <ArticleId IdType="pubmed">19114476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wessels MR, Kasper DL. 
1993. 
The changing spectrum of group B streptococcal disease. N Engl J Med
328:1843–1844. doi:10.1056/NEJM199306243282510.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1056/NEJM199306243282510</ArticleId>
            <ArticleId IdType="pubmed">8502275</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Slotved HC, Kong F, Lambertsen L, Sauer S, Gilbert GL. 
2007. 
Serotype IX, a proposed new Streptococcus agalactiae serotype. J Clin Microbiol
45:2929–2936. doi:10.1128/JCM.00117-07.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JCM.00117-07</ArticleId>
            <ArticleId IdType="pmc">PMC2045254</ArticleId>
            <ArticleId IdType="pubmed">17634306</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kothari NJ, Morin CA, Glennen A, Jackson D, Harper J, Schrag SJ, Lynfield R. 
2009. 
Invasive group B streptococcal disease in the elderly, Minnesota, USA, 2003–2007. Emerg Infect Dis
15:1279–1281. doi:10.3201/eid1508.081381.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3201/eid1508.081381</ArticleId>
            <ArticleId IdType="pmc">PMC2815956</ArticleId>
            <ArticleId IdType="pubmed">19751591</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Skoff TH, Farley MM, Petit S, Craig AS, Schaffner W, Gershman K, Harrison LH, Lynfield R, Mohle-Boetani J, Zansky S, Albanese BA, Stefonek K, Zell ER, Jackson D, Thompson T, Schrag SJ. 
2009. 
Increasing burden of invasive group B streptococcal disease in nonpregnant adults, 1990–2007. Clin Infect Dis
49:85–92. doi:10.1086/599369.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/599369</ArticleId>
            <ArticleId IdType="pubmed">19480572</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blumberg HM, Stephens DS, Modansky M, Erwin M, Elliot J, Facklam RR, Schuchat A, Baughman W, Farley MM. 
1996. 
Invasive group B streptococcal disease: the emergence of serotype V. J Infect Dis
173:365–373. doi:10.1093/infdis/173.2.365.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/173.2.365</ArticleId>
            <ArticleId IdType="pubmed">8568297</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooven TA, Randis TM, Daugherty SC, Narechania A, Planet PJ, Tettelin H, Ratner AJ. 
2014. 
Complete genome sequence of Streptococcus agalactiae CNCTC 10/84, a hypervirulent sequence type 26 strain. Genome Announc
2:e01338-14. doi:10.1128/genomeA.01338-14.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/genomeA.01338-14</ArticleId>
            <ArticleId IdType="pmc">PMC4276828</ArticleId>
            <ArticleId IdType="pubmed">25540350</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Randis TM, Gelber SE, Hooven TA, Abellar RG, Akabas LH, Lewis EL, Walker LB, Byland LM, Nizet V, Ratner AJ. 
2014. 
Group B Streptococcus beta-hemolysin/cytolysin breaches maternal-fetal barriers to cause preterm birth and intrauterine fetal demise in vivo. J Infect Dis
210:265–273. doi:10.1093/infdis/jiu067.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiu067</ArticleId>
            <ArticleId IdType="pmc">PMC4092248</ArticleId>
            <ArticleId IdType="pubmed">24474814</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patras KA, Doran KS. 
2016. 
A murine model of group B Streptococcus vaginal colonization. J Vis Exp
2016:54708. doi:10.3791/54708.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3791/54708</ArticleId>
            <ArticleId IdType="pmc">PMC5226234</ArticleId>
            <ArticleId IdType="pubmed">27911391</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doran KS, Liu GY, Nizet V. 
2003. 
Group B streptococcal beta-hemolysin/cytolysin activates neutrophil signaling pathways in brain endothelium and contributes to development of meningitis. J Clin Investig
112:736–744. doi:10.1172/JCI200317335.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI200317335</ArticleId>
            <ArticleId IdType="pmc">PMC182187</ArticleId>
            <ArticleId IdType="pubmed">12952922</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Patras KA, Derieux J, Al-Bassam MM, Adiletta N, Vrbanac A, Lapek JD, Zengler K, Gonzalez DJ, Nizet V. 
2018. 
Group B Streptococcus biofilm regulatory protein A contributes to bacterial physiology and innate immune resistance. J Infect Dis
218:1641–1652. doi:10.1093/infdis/jiy341.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiy341</ArticleId>
            <ArticleId IdType="pmc">PMC6173572</ArticleId>
            <ArticleId IdType="pubmed">29868829</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kulkarni R, Randis TM, Antala S, Wang A, Amaral FE, Ratner AJ. 
2013. 
Beta-hemolysin/cytolysin of Group B Streptococcus enhances host inflammation but is dispensable for establishment of urinary tract infection. PLoS One
8:e59091. doi:10.1371/journal.pone.0059091.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0059091</ArticleId>
            <ArticleId IdType="pmc">PMC3591438</ArticleId>
            <ArticleId IdType="pubmed">23505569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lin SM, Jang AY, Zhi Y, Gao S, Lim S, Lim JH, Song JY, Sullam PM, Rhee JH, Seo HS. 
2017. 
Vaccination with a latch peptide provides serotype-independent protection against group B Streptococcus infection in mice. J Infect Dis
217:93–102. doi:10.1093/infdis/jix565.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jix565</ArticleId>
            <ArticleId IdType="pmc">PMC5854025</ArticleId>
            <ArticleId IdType="pubmed">29106586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gendrin C, Vornhagen J, Ngo L, Whidbey C, Boldenow E, Santana-Ufret V, Clauson M, Burnside K, Galloway DP, Adams Waldorf KM, Piliponsky AM, Rajagopal L. 
2015. 
Mast cell degranulation by a hemolytic lipid toxin decreases GBS colonization and infection. Sci Adv
1:e1400225. doi:10.1126/sciadv.1400225.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1126/sciadv.1400225</ArticleId>
            <ArticleId IdType="pmc">PMC4584422</ArticleId>
            <ArticleId IdType="pubmed">26425734</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Banerjee A, Kim BJ, Carmona EM, Cutting AS, Gurney MA, Carlos C, Feuer R, Prasadarao NV, Doran KS. 
2011. 
Bacterial pili exploit integrin machinery to promote immune activation and efficient blood-brain barrier penetration. Nat Commun
2:462. doi:10.1038/ncomms1474.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncomms1474</ArticleId>
            <ArticleId IdType="pmc">PMC3195231</ArticleId>
            <ArticleId IdType="pubmed">21897373</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>van Sorge NM, Quach D, Gurney MA, Sullam PM, Nizet V, Doran KS. 
2009. 
The group B streptococcal serine-rich repeat 1 glycoprotein mediates penetration of the blood-brain barrier. J Infect Dis
199:1479–1487. doi:10.1086/598217.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1086/598217</ArticleId>
            <ArticleId IdType="pmc">PMC2674616</ArticleId>
            <ArticleId IdType="pubmed">19392623</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wang NY, Patras KA, Seo HS, Cavaco CK, Rosler B, Neely MN, Sullam PM, Doran KS. 
2014. 
Group B streptococcal serine-rich repeat proteins promote interaction with fibrinogen and vaginal colonization. J Infect Dis
210:982–991. doi:10.1093/infdis/jiu151.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/infdis/jiu151</ArticleId>
            <ArticleId IdType="pmc">PMC4192050</ArticleId>
            <ArticleId IdType="pubmed">24620021</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Alkuwaity K, Taylor A, Heckels JE, Doran KS, Christodoulides M. 
2012. 
Group B Streptococcus interactions with human meningeal cells and astrocytes in vitro. PLoS One
7:e42660. doi:10.1371/journal.pone.0042660.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0042660</ArticleId>
            <ArticleId IdType="pmc">PMC3416839</ArticleId>
            <ArticleId IdType="pubmed">22900037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cutting AS, Del Rosario Y, Mu R, Rodriguez A, Till A, Subramani S, Gottlieb RA, Doran KS. 
2014. 
The role of autophagy during group B Streptococcus infection of blood-brain barrier endothelium. J Biol Chem
289:35711–35723. doi:10.1074/jbc.M114.588657.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M114.588657</ArticleId>
            <ArticleId IdType="pmc">PMC4276841</ArticleId>
            <ArticleId IdType="pubmed">25371213</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pritzlaff CA, Chang JC, Kuo SP, Tamura GS, Rubens CE, Nizet V. 
2001. 
Genetic basis for the beta-haemolytic/cytolytic activity of group B Streptococcus. Mol Microbiol
39:236–247. doi:10.1046/j.1365-2958.2001.02211.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2958.2001.02211.x</ArticleId>
            <ArticleId IdType="pubmed">11136446</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hooven TA, Bonakdar M, Chamby AB, Ratner AJ. 
2019. 
A counterselectable sucrose sensitivity marker permits efficient and flexible mutagenesis in Streptococcus agalactiae. Appl Environ Microbiol
85:e03009-18. doi:10.1128/AEM.03009-18.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AEM.03009-18</ArticleId>
            <ArticleId IdType="pmc">PMC6585494</ArticleId>
            <ArticleId IdType="pubmed">30658970</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seo HS, Mu R, Kim BJ, Doran KS, Sullam PM. 
2012. 
Binding of glycoprotein Srr1 of Streptococcus agalactiae to fibrinogen promotes attachment to brain endothelium and the development of meningitis. PLoS Pathog
8:e1002947. doi:10.1371/journal.ppat.1002947.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1002947</ArticleId>
            <ArticleId IdType="pmc">PMC3464228</ArticleId>
            <ArticleId IdType="pubmed">23055927</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maisey HC, Hensler M, Nizet V, Doran KS. 
2007. 
Group B streptococcal pilus proteins contribute to adherence to and invasion of brain microvascular endothelial cells. J Bacteriol
189:1464–1467. doi:10.1128/JB.01153-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01153-06</ArticleId>
            <ArticleId IdType="pmc">PMC1797338</ArticleId>
            <ArticleId IdType="pubmed">17041051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim BJ, Bee OB, McDonagh MA, Stebbins MJ, Palecek SP, Doran KS, Shusta EV. 
2017. 
Modeling group B Streptococcus and blood-brain barrier interaction by using induced pluripotent stem cell-derived brain endothelial cells. mSphere
2:e00398-17. doi:10.1128/mSphere.00398-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSphere.00398-17</ArticleId>
            <ArticleId IdType="pmc">PMC5663983</ArticleId>
            <ArticleId IdType="pubmed">29104935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charbonneau ARL, Forman OP, Cain AK, Newland G, Robinson C, Boursnell M, Parkhill J, Leigh JA, Maskell DJ, Waller AS. 
2017. 
Defining the ABC of gene essentiality in streptococci. BMC Genomics
18:426. doi:10.1186/s12864-017-3794-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1186/s12864-017-3794-3</ArticleId>
            <ArticleId IdType="pmc">PMC5452409</ArticleId>
            <ArticleId IdType="pubmed">28569133</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maguin E, Prevost H, Ehrlich SD, Gruss A. 
1996. 
Efficient insertional mutagenesis in lactococci and other gram-positive bacteria. J Bacteriol
178:931–935. doi:10.1128/jb.178.3.931-935.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.178.3.931-935.1996</ArticleId>
            <ArticleId IdType="pmc">PMC177749</ArticleId>
            <ArticleId IdType="pubmed">8550537</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu L, Charbonneau ARL, Waller AS, Olsen RJ, Beres SB, Musser JM. 
2017. 
Novel genes required for the fitness of Streptococcus pyogenes in human saliva. mSphere
2:e00460-17. doi:10.1128/mSphereDirect.00460-17.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mSphereDirect.00460-17</ArticleId>
            <ArticleId IdType="pmc">PMC5663985</ArticleId>
            <ArticleId IdType="pubmed">29104937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu L, Olsen RJ, Beres SB, Eraso JM, Saavedra MO, Kubiak SL, Cantu CC, Jenkins L, Charbonneau ARL, Waller AS, Musser JM. 
2019. 
Gene fitness landscape of group A streptococcus during necrotizing myositis. J Clin Investig
129:887–901. doi:10.1172/JCI124994.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI124994</ArticleId>
            <ArticleId IdType="pmc">PMC6355216</ArticleId>
            <ArticleId IdType="pubmed">30667377</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Charbonneau ARL, Taylor E, Mitchell CJ, Robinson C, Cain AK, Leigh JA, Maskell DJ, Waller AS. 
2020. 
Identification of genes required for the fitness of Streptococcus equi subsp. equi in whole equine blood and hydrogen peroxide. Microb Genom
6:e000362. doi:10.1099/mgen.0.000362.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1099/mgen.0.000362</ArticleId>
            <ArticleId IdType="pmc">PMC7276704</ArticleId>
            <ArticleId IdType="pubmed">32228801</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones AL, Needham RH, Clancy A, Knoll KM, Rubens CE. 
2003. 
Penicillin-binding proteins in Streptococcus agalactiae: a novel mechanism for evasion of immune clearance. Mol Microbiol
47:247–256. doi:10.1046/j.1365-2958.2003.03297.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1046/j.1365-2958.2003.03297.x</ArticleId>
            <ArticleId IdType="pubmed">12492868</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hamilton A, Popham DL, Carl DJ, Lauth X, Nizet V, Jones AL. 
2006. 
Penicillin-binding protein 1a promotes resistance of group B streptococcus to antimicrobial peptides. Infect Immun
74:6179–6187. doi:10.1128/IAI.00895-06.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00895-06</ArticleId>
            <ArticleId IdType="pmc">PMC1695509</ArticleId>
            <ArticleId IdType="pubmed">17057092</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rajagopal L, Vo A, Silvestroni A, Rubens CE. 
2006. 
Regulation of cytotoxin expression by converging eukaryotic-type and two-component signalling mechanisms in Streptococcus agalactiae. Mol Microbiol
62:941–957. doi:10.1111/j.1365-2958.2006.05431.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2006.05431.x</ArticleId>
            <ArticleId IdType="pmc">PMC2593684</ArticleId>
            <ArticleId IdType="pubmed">17005013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shelver D, Rajagopal L, Harris TO, Rubens CE. 
2003. 
MtaR, a regulator of methionine transport, is critical for survival of group B streptococcus in vivo. J Bacteriol
185:6592–6599. doi:10.1128/jb.185.22.6592-6599.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/jb.185.22.6592-6599.2003</ArticleId>
            <ArticleId IdType="pmc">PMC262094</ArticleId>
            <ArticleId IdType="pubmed">14594832</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poyart C, Pellegrini E, Gaillot O, Boumaila C, Baptista M, Trieu-Cuot P. 
2001. 
Contribution of Mn-cofactored superoxide dismutase (SodA) to the virulence of Streptococcus agalactiae. Infect Immun
69:5098–5106. doi:10.1128/IAI.69.8.5098-5106.2001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.69.8.5098-5106.2001</ArticleId>
            <ArticleId IdType="pmc">PMC98605</ArticleId>
            <ArticleId IdType="pubmed">11447191</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Janulczyk R, Ricci S, Bjorck L. 
2003. 
MtsABC is important for manganese and iron transport, oxidative stress resistance, and virulence of Streptococcus pyogenes. Infect Immun
71:2656–2664. doi:10.1128/iai.71.5.2656-2664.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.71.5.2656-2664.2003</ArticleId>
            <ArticleId IdType="pmc">PMC153223</ArticleId>
            <ArticleId IdType="pubmed">12704140</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herrmann KM.
1995. 
The shikimate pathway: early steps in the biosynthesis of aromatic compounds. Plant Cell
7:907–919. doi:10.1105/tpc.7.7.907.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1105/tpc.7.7.907</ArticleId>
            <ArticleId IdType="pmc">PMC160886</ArticleId>
            <ArticleId IdType="pubmed">12242393</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mistou MY, Dramsi S, Brega S, Poyart C, Trieu-Cuot P. 
2009. 
Molecular dissection of the secA2 locus of group B Streptococcus reveals that glycosylation of the Srr1 LPXTG protein is required for full virulence. J Bacteriol
191:4195–4206. doi:10.1128/JB.01673-08.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.01673-08</ArticleId>
            <ArticleId IdType="pmc">PMC2698466</ArticleId>
            <ArticleId IdType="pubmed">19395494</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seo HS, Minasov G, Seepersaud R, Doran KS, Dubrovska I, Shuvalova L, Anderson WF, Iverson TM, Sullam PM. 
2013. 
Characterization of fibrinogen binding by glycoproteins Srr1 and Srr2 of Streptococcus agalactiae. J Biol Chem
288:35982–35996. doi:10.1074/jbc.M113.513358.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M113.513358</ArticleId>
            <ArticleId IdType="pmc">PMC3861647</ArticleId>
            <ArticleId IdType="pubmed">24165132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Seo HS, Xiong YQ, Sullam PM. 
2013. 
Role of the serine-rich surface glycoprotein Srr1 of Streptococcus agalactiae in the pathogenesis of infective endocarditis. PLoS One
8:e64204. doi:10.1371/journal.pone.0064204.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0064204</ArticleId>
            <ArticleId IdType="pmc">PMC3662765</ArticleId>
            <ArticleId IdType="pubmed">23717569</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vornhagen J, Adams Waldorf KM, Rajagopal L. 
2017. 
Perinatal group B streptococcal infections: virulence factors, immunity, and prevention strategies. Trends Microbiol
25:919–931. doi:10.1016/j.tim.2017.05.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tim.2017.05.013</ArticleId>
            <ArticleId IdType="pmc">PMC5650539</ArticleId>
            <ArticleId IdType="pubmed">28633864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lindahl G, Stalhammar-Carlemalm M, Areschoug T. 
2005. 
Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens. Clin Microbiol Rev
18:102–127. doi:10.1128/CMR.18.1.102-127.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/CMR.18.1.102-127.2005</ArticleId>
            <ArticleId IdType="pmc">PMC544178</ArticleId>
            <ArticleId IdType="pubmed">15653821</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liu GY, Nizet V. 
2004. 
Extracellular virulence factors of group B streptococci. Front Biosci
9:1794–1802. doi:10.2741/1296.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2741/1296</ArticleId>
            <ArticleId IdType="pubmed">14977587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Doran KS, Nizet V. 
2004. 
Molecular pathogenesis of neonatal group B streptococcal infection: no longer in its infancy. Mol Microbiol
54:23–31. doi:10.1111/j.1365-2958.2004.04266.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2004.04266.x</ArticleId>
            <ArticleId IdType="pubmed">15458402</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Eijkelkamp BA, McDevitt CA, Kitten T. 
2015. 
Manganese uptake and streptococcal virulence. Biometals
28:491–508. doi:10.1007/s10534-015-9826-z.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s10534-015-9826-z</ArticleId>
            <ArticleId IdType="pmc">PMC5800397</ArticleId>
            <ArticleId IdType="pubmed">25652937</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Papp-Wallace KM, Maguire ME. 
2006. 
Manganese transport and the role of manganese in virulence. Annu Rev Microbiol
60:187–209. doi:10.1146/annurev.micro.60.080805.142149.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev.micro.60.080805.142149</ArticleId>
            <ArticleId IdType="pubmed">16704341</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner AG, Ong CL, Gillen CM, Davies MR, West NP, McEwan AG, Walker MJ. 
2015. 
Manganese homeostasis in group A Streptococcus is critical for resistance to oxidative stress and virulence. mBio
6:e00278-15. doi:10.1128/mBio.00278-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.00278-15</ArticleId>
            <ArticleId IdType="pmc">PMC4453566</ArticleId>
            <ArticleId IdType="pubmed">25805729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Do H, Makthal N, Chandrangsu P, Olsen RJ, Helmann JD, Musser JM, Kumaraswami M. 
2019. 
Metal sensing and regulation of adaptive responses to manganese limitation by MtsR is critical for group A streptococcus virulence. Nucleic Acids Res
47:8333–8334. doi:10.1093/nar/gkz641.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/nar/gkz641</ArticleId>
            <ArticleId IdType="pmc">PMC6736032</ArticleId>
            <ArticleId IdType="pubmed">31329935</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Colomer-Winter C, Flores-Mireles AL, Baker SP, Frank KL, Lynch AJL, Hultgren SJ, Kitten T, Lemos JA. 
2018. 
Manganese acquisition is essential for virulence of Enterococcus faecalis. PLoS Pathog
14:e1007102. doi:10.1371/journal.ppat.1007102.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.ppat.1007102</ArticleId>
            <ArticleId IdType="pmc">PMC6147510</ArticleId>
            <ArticleId IdType="pubmed">30235334</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ouyang Z, He M, Oman T, Yang XF, Norgard MV. 
2009. 
A manganese transporter, BB0219 (BmtA), is required for virulence by the Lyme disease spirochete, Borrelia burgdorferi. Proc Natl Acad Sci U S A
106:3449–3454. doi:10.1073/pnas.0812999106.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.0812999106</ArticleId>
            <ArticleId IdType="pmc">PMC2651281</ArticleId>
            <ArticleId IdType="pubmed">19218460</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Aguirre JD, Culotta VC. 
2012. 
Battles with iron: manganese in oxidative stress protection. J Biol Chem
287:13541–13548. doi:10.1074/jbc.R111.312181.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.R111.312181</ArticleId>
            <ArticleId IdType="pmc">PMC3340200</ArticleId>
            <ArticleId IdType="pubmed">22247543</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Inaoka T, Matsumura Y, Tsuchido T. 
1999. 
SodA and manganese are essential for resistance to oxidative stress in growing and sporulating cells of Bacillus subtilis. J Bacteriol
181:1939–1943. doi:10.1128/JB.181.6.1939-1943.1999.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.181.6.1939-1943.1999</ArticleId>
            <ArticleId IdType="pmc">PMC93599</ArticleId>
            <ArticleId IdType="pubmed">10074093</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Padilla E, Llobet E, Doménech-Sánchez A, Martínez-Martínez L, Bengoechea JA, Albertí S. 
2010. 
Klebsiella pneumoniae AcrAB efflux pump contributes to antimicrobial resistance and virulence. Antimicrob Agents Chemother
54:177–183. doi:10.1128/AAC.00715-09.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/AAC.00715-09</ArticleId>
            <ArticleId IdType="pmc">PMC2798511</ArticleId>
            <ArticleId IdType="pubmed">19858254</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li M, Cha DJ, Lai Y, Villaruz AE, Sturdevant DE, Otto M. 
2007. 
The antimicrobial peptide-sensing system aps of Staphylococcus aureus. Mol Microbiol
66:1136–1147. doi:10.1111/j.1365-2958.2007.05986.x.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/j.1365-2958.2007.05986.x</ArticleId>
            <ArticleId IdType="pubmed">17961141</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tzeng YL, Ambrose KD, Zughaier S, Zhou X, Miller YK, Shafer WM, Stephens DS. 
2005. 
Cationic antimicrobial peptide resistance in Neisseria meningitidis. J Bacteriol
187:5387–5396. doi:10.1128/JB.187.15.5387-5396.2005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/JB.187.15.5387-5396.2005</ArticleId>
            <ArticleId IdType="pmc">PMC1196002</ArticleId>
            <ArticleId IdType="pubmed">16030233</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Voyich JM, Braughton KR, Sturdevant DE, Vuong C, Kobayashi SD, Porcella SF, Otto M, Musser JM, DeLeo FR. 
2004. 
Engagement of the pathogen survival response used by group A Streptococcus to avert destruction by innate host defense. J Immunol
173:1194–1201. doi:10.4049/jimmunol.173.2.1194.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.173.2.1194</ArticleId>
            <ArticleId IdType="pubmed">15240710</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Maeda H, Dudareva N. 
2012. 
The shikimate pathway and aromatic amino acid biosynthesis in plants. Annu Rev Plant Biol
63:73–105. doi:10.1146/annurev-arplant-042811-105439.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-arplant-042811-105439</ArticleId>
            <ArticleId IdType="pubmed">22554242</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Felgner S, Frahm M, Kocijancic D, Rohde M, Eckweiler D, Bielecka A, Bueno E, Cava F, Abraham WR, Curtiss R III, Haussler S, Erhardt M, Weiss S. 
2016. 
aroA-deficient Salmonella enterica serovar Typhimurium is more than a metabolically attenuated mutant. mBio
7:e01220-16. doi:10.1128/mBio.01220-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/mBio.01220-16</ArticleId>
            <ArticleId IdType="pmc">PMC5013297</ArticleId>
            <ArticleId IdType="pubmed">27601574</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stritzker J, Janda J, Schoen C, Taupp M, Pilgrim S, Gentschev I, Schreier P, Geginat G, Goebel W. 
2004. 
Growth, virulence, and immunogenicity of Listeria monocytogenes aro mutants. Infect Immun
72:5622–5629. doi:10.1128/IAI.72.10.5622-5629.2004.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.72.10.5622-5629.2004</ArticleId>
            <ArticleId IdType="pmc">PMC517589</ArticleId>
            <ArticleId IdType="pubmed">15385459</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jones SC, Price CT, Santic M, Abu Kwaik Y. 
2015. 
Selective requirement of the shikimate pathway of Legionella pneumophila for intravacuolar growth within human macrophages but not within Acanthamoeba. Infect Immun
83:2487–2495. doi:10.1128/IAI.00294-15.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.00294-15</ArticleId>
            <ArticleId IdType="pmc">PMC4432756</ArticleId>
            <ArticleId IdType="pubmed">25847958</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hoiseth SK, Stocker BA. 
1981. 
Aromatic-dependent Salmonella typhimurium are non-virulent and effective as live vaccines. Nature
291:238–239. doi:10.1038/291238a0.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/291238a0</ArticleId>
            <ArticleId IdType="pubmed">7015147</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kotloff KL, Noriega F, Losonsky GA, Sztein MB, Wasserman SS, Nataro JP, Levine MM. 
1996. 
Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect Immun
64:4542–4548. doi:10.1128/IAI.64.11.4542-4548.1996.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.64.11.4542-4548.1996</ArticleId>
            <ArticleId IdType="pmc">PMC174410</ArticleId>
            <ArticleId IdType="pubmed">8890204</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Priebe GP, Meluleni GJ, Coleman FT, Goldberg JB, Pier GB. 
2003. 
Protection against fatal Pseudomonas aeruginosa pneumonia in mice after nasal immunization with a live, attenuated aroA deletion mutant. Infect Immun
71:1453–1461. doi:10.1128/iai.71.3.1453-1461.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/iai.71.3.1453-1461.2003</ArticleId>
            <ArticleId IdType="pmc">PMC148856</ArticleId>
            <ArticleId IdType="pubmed">12595463</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Roberts M, Maskell D, Novotny P, Dougan G. 
1990. 
Construction and characterization in vivo of Bordetella pertussis aroA mutants. Infect Immun
58:732–739. doi:10.1128/IAI.58.3.732-739.1990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.58.3.732-739.1990</ArticleId>
            <ArticleId IdType="pmc">PMC258526</ArticleId>
            <ArticleId IdType="pubmed">2407655</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chamberlain LM, Strugnell R, Dougan G, Hormaeche CE, Demarco de Hormaeche R. 
1993. 
Neisseria gonorrhoeae strain MS11 harbouring a mutation in gene aroA is attenuated and immunogenic. Microb Pathog
15:51–63. doi:10.1006/mpat.1993.1056.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/mpat.1993.1056</ArticleId>
            <ArticleId IdType="pubmed">8412627</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ivins BE, Welkos SL, Knudson GB, Little SF. 
1990. 
Immunization against anthrax with aromatic compound-dependent (Aro-) mutants of Bacillus anthracis and with recombinant strains of Bacillus subtilis that produce anthrax protective antigen. Infect Immun
58:303–308. doi:10.1128/IAI.58.2.303-308.1990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/IAI.58.2.303-308.1990</ArticleId>
            <ArticleId IdType="pmc">PMC258455</ArticleId>
            <ArticleId IdType="pubmed">2105269</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pahlman LI, Morgelin M, Kasetty G, Olin AI, Schmidtchen A, Herwald H. 
2013. 
Antimicrobial activity of fibrinogen and fibrinogen-derived peptides–a novel link between coagulation and innate immunity. Thromb Haemost
109:930–939. doi:10.1160/TH12-10-0739.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1160/TH12-10-0739</ArticleId>
            <ArticleId IdType="pubmed">23467586</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Loof TG, Deicke C, Medina E. 
2014. 
The role of coagulation/fibrinolysis during Streptococcus pyogenes infection. Front Cell Infect Microbiol
4:128. doi:10.3389/fcimb.2014.00128.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fcimb.2014.00128</ArticleId>
            <ArticleId IdType="pmc">PMC4161043</ArticleId>
            <ArticleId IdType="pubmed">25309880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Thavasu PW, Longhurst S, Joel SP, Slevin ML, Balkwill FR. 
1992. 
Measuring cytokine levels in blood. Importance of anticoagulants, processing, and storage conditions. J Immunol Methods
153:115–124. doi:10.1016/0022-1759(92)90313-i.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/0022-1759(92)90313-i</ArticleId>
            <ArticleId IdType="pubmed">1381403</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhu L, Olsen RJ, Nasser W, Beres SB, Vuopio J, Kristinsson KG, Gottfredsson M, Porter AR, DeLeo FR, Musser JM. 
2015. 
A molecular trigger for intercontinental epidemics of group A Streptococcus. J Clin Investig
125:3545–3559. doi:10.1172/JCI82478.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI82478</ArticleId>
            <ArticleId IdType="pmc">PMC4588293</ArticleId>
            <ArticleId IdType="pubmed">26258415</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
